Filing Flows › BioAge Labs (BIOA) › Recalls, complaints & regulation
BioAge Labs (BIOA): clinical trials
BioAge Labs (BIOA) beyond its filings: 2 active clinical trials.
BioAge Labs' latest quarter
BioAge Labs, Q3 2026: revenue $298K (-86% year over year), net loss $33.5M, operating cash flow −$31.0M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does BioAge Labs have?
2 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.